Quantitative Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Quantitative Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-77,106	Closed	-$4.12M	–	473
2020 Q4	$4.12M	Buy	+77,106	New	+$3.83M	0.33%	67
2020 Q3	–	Sell	-24,201	Closed	-$1.17M	–	374
2020 Q2	$1.17M	Buy	+24,201	New	+$1.16M	0.12%	185
2019 Q4	–	Sell	-245,234	Closed	-$8.82M	–	611
2019 Q3	$8.82M	Buy	245,234 +207,319	+547%	+$6.29M	0.47%	49
2019 Q2	$1.01M	Buy	37,915 +12,215	+48%	+$312K	0.04%	408
2019 Q1	$690K	Buy	+25,700	New	+$600K	0.04%	437
2018 Q4	–	Sell	-97,500	Closed	-$2.02M	–	540
2018 Q3	$2.02M	Buy	+97,500	New	+$1.53M	0.07%	193
2017 Q2	–	Sell	-41,500	Closed	-$1.43M	–	668
2017 Q1	$1.43M	Buy	+41,500	New	+$1.46M	0.02%	518
2016 Q3	–	Sell	-91,200	Closed	-$2.96M	–	653
2016 Q2	$2.96M	Buy	+91,200	New	+$3.05M	0.14%	222
2015 Q3	–	Sell	-6,300	Closed	-$263K	–	667
2015 Q2	$263K	Buy	+6,300	New	+$244K	0.04%	341
2015 Q1	–	Sell	-9,100	Closed	-$288K	–	602
2014 Q4	$288K	Sell	9,100 -6,300	-41%	-$179K	0.04%	359
2014 Q3	$381K	Buy	+15,400	New	+$360K	0.07%	208
2014 Q1	–	Sell	-23,500	Closed	-$587K	–	521
2013 Q4	$587K	Buy	+23,500	New	+$554K	0.06%	301

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Quantitative Investment Management's ACAD Position: Q1 2021 in Review

Quantitative Investment Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2021, closing a stake of 77,106 shares — an estimated $4.12M sold.

Quantitative Investment Management first reported a position in ACAD in Q4 2013 and held it in 12 quarters. The position peaked at $8.82M in Q3 2019. 272 funds tracked by Wall St. Rank hold ACAD as of Q1 2021.

Quantitative Investment Management reported no remaining Acadia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Quantitative Investment Management sold 77,106 Acadia Pharmaceuticals shares in Q1 2021, an estimated $4.12M.
Quantitative Investment Management first reported a position in Acadia Pharmaceuticals in Q4 2013 and held it in 12 quarters.
Quantitative Investment Management's Acadia Pharmaceuticals position peaked at $8.82M in Q3 2019.
272 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2021.

Based on Quantitative Investment Management's 13F filing for Q1 2021, filed 17 May 2021.